肝硬化患者结直肠内镜黏膜切除术后息肉切除后出血风险:美国协作网络倾向匹配分析
这项回顾性队列研究利用美国协作网络数据,比较肝硬化患者与对照组结直肠内镜黏膜切除术后息肉切除后出血风险。倾向评分匹配后各组2381例,肝硬化患者出血风险更高(OR 1.38,95%CI 1.05-1.82,P=0.02),出血风险升高主要见于失代偿期肝硬化(OR 1.65,95%CI 1.12-2.42,P=0.01),代偿期肝硬化未见风险增加。内镜下止血再干预率两组相似。
要点
- 肝硬化患者结直肠EMR后30天内息肉切除后出血风险高于对照(OR 1.38)。
- 失代偿期肝硬化出血风险显著升高(OR 1.65),代偿期肝硬化未见增加。
- 内镜下止血再干预率肝硬化与对照相似(OR 1.20,95%CI 0.71-2.05,P=0.50)。
核心结论
- 失代偿期肝硬化患者结直肠EMR后息肉切除后出血风险较高,代偿期肝硬化患者出血风险未增加。
- 优化肝硬化患者(尤其失代偿期)状态并在结直肠EMR后监测出血仍然重要。
- 对肝硬化患者出血采取保守、支持性处理可能与非肝硬化患者同样有效。
研究设计与样本
- 回顾性队列研究,使用美国协作网络评估肝硬化患者与对照者结直肠EMR后息肉切除后出血风险。
- 采用一对一倾向评分匹配,匹配后肝硬化组与对照组各2381例。
- 主要结局为EMR后30天内出血,并按肝硬化严重程度(代偿期与失代偿期)分层分析。
主要发现
- 匹配后肝硬化组息肉切除后出血风险高于对照组(OR 1.38,95%CI 1.05-1.82,P=0.02)。
- 内镜下止血再干预在肝硬化组与对照组之间相似(OR 1.20,95%CI 0.71-2.05,P=0.50)。
- 失代偿期肝硬化组息肉切除后出血风险显著高于对照(OR 1.65,95%CI 1.12-2.42,P=0.01)。
- 代偿期肝硬化组息肉切除后出血风险未见增加(OR 1.15,95%CI 0.85-1.54,P=0.37)。
临床怎么用
- 优化肝硬化患者(尤其失代偿期)状态并在结直肠EMR后监测出血仍然重要。
- 对肝硬化患者出血采取保守、支持性处理可能与非肝硬化患者同样有效(作者认为)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Data on the risk of post-polypectomy bleeding after endoscopic mucosal resection (EMR) in patients with cirrhosis are limited. METHODS: This retrospective cohort study used the US Collaborative Network to assess post-polypectomy bleeding risk after colorectal EMR in patients with cirrhosis compared with controls. Using one-to-one propensity score matching, the primary outcome measured was bleeding within 30 days post-EMR. The bleeding risk was further stratified by cirrhosis severity (compensated and decompensated). RESULTS: After propensity score matching, each cohort included 2,381 patients. Patients with cirrhosis had a higher risk of post-polypectomy bleeding (odds ratio [OR] 1.38, 95% confidence interval [CI] 1.05-1.82, P = 0.02). However, endoscopic reinterventions for hemostasis were similar between cirrhosis and control cohorts (OR 1.20, 95% CI 0.71-2.05, P = 0.50). The post-polypectomy bleeding risk was significantly higher in patients with decompensated cirrhosis (OR 1.65, 95% CI 1.12-2.42, P = 0.01), while those with compensated cirrhosis showed no increased risk of post-polypectomy bleeding (OR 1.15, 95% CI 0.85-1.54, P = 0.37). DISCUSSION: The post-polypectomy bleeding risk was higher in patients with decompensated cirrhosis, while the bleeding risk was not increased in those with compensated disease. Optimizing patients with cirrhosis, especially with decompensated disease, before colorectal EMR and monitoring for post-procedure bleeding remain important. A conservative, supportive approach to managing bleeding in patients with cirrhosis may be as effective as in those without cirrhosis.
引用
- Beran A, Elfert K, Patel FN, et al. Risk of Post-polypectomy Bleeding After Colorectal Endoscopic Mucosal Resection in Patients With Cirrhosis: A Propensity-Matched Analysis of the US Collaborative Network. Am J Gastroenterol. 2025. PMID: 39950371. doi:10.14309/ajg.0000000000003322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。